The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Bioanalysis Services Market Research Report 2025
Synopsis
Bioanalytical services are provided to researchers by contract research organizations who have the resources, expertise, instrumentation, and technology to tackle the most complex programs across multiple modalities and therapeutic areas for clinical and preclinical bioanalysis.
The global Drug Bioanalysis Services market was valued at US$ 1401 million in 2023 and is anticipated to reach US$ 1916.5 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Bioanalysis Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Bioanalysis Services.
Report Scope
The Drug Bioanalysis Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Bioanalysis Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Bioanalysis Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Intertek
SGS
Medicilon
PPD, Inc.
ICON Plc
Eurofins Scientific
Charles River Laboratories International
Impact Analytical
QPS
Frontage Laboratories
ACM Global Laboratories
Segment by Type
Macro Molecular Drug Bioanalysis
Small Molecule Drug Bioanalysis
Segment by Application
Pharmaceutical Development Corporation
Hospital
Academic Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Bioanalysis Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Bioanalytical services are provided to researchers by contract research organizations who have the resources, expertise, instrumentation, and technology to tackle the most complex programs across multiple modalities and therapeutic areas for clinical and preclinical bioanalysis.
The global Drug Bioanalysis Services market was valued at US$ 1401 million in 2023 and is anticipated to reach US$ 1916.5 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Bioanalysis Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Bioanalysis Services.
Report Scope
The Drug Bioanalysis Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Bioanalysis Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Bioanalysis Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Intertek
SGS
Medicilon
PPD, Inc.
ICON Plc
Eurofins Scientific
Charles River Laboratories International
Impact Analytical
QPS
Frontage Laboratories
ACM Global Laboratories
Segment by Type
Macro Molecular Drug Bioanalysis
Small Molecule Drug Bioanalysis
Segment by Application
Pharmaceutical Development Corporation
Hospital
Academic Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Bioanalysis Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Bioanalysis Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Macro Molecular Drug Bioanalysis
1.2.3 Small Molecule Drug Bioanalysis
1.3 Market by Application
1.3.1 Global Drug Bioanalysis Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Development Corporation
1.3.3 Hospital
1.3.4 Academic Research Institute
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Bioanalysis Services Market Perspective (2019-2030)
2.2 Drug Bioanalysis Services Growth Trends by Region
2.2.1 Global Drug Bioanalysis Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Bioanalysis Services Historic Market Size by Region (2019-2024)
2.2.3 Drug Bioanalysis Services Forecasted Market Size by Region (2025-2030)
2.3 Drug Bioanalysis Services Market Dynamics
2.3.1 Drug Bioanalysis Services Industry Trends
2.3.2 Drug Bioanalysis Services Market Drivers
2.3.3 Drug Bioanalysis Services Market Challenges
2.3.4 Drug Bioanalysis Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Bioanalysis Services Players by Revenue
3.1.1 Global Top Drug Bioanalysis Services Players by Revenue (2019-2024)
3.1.2 Global Drug Bioanalysis Services Revenue Market Share by Players (2019-2024)
3.2 Global Drug Bioanalysis Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Bioanalysis Services Revenue
3.4 Global Drug Bioanalysis Services Market Concentration Ratio
3.4.1 Global Drug Bioanalysis Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Bioanalysis Services Revenue in 2023
3.5 Drug Bioanalysis Services Key Players Head office and Area Served
3.6 Key Players Drug Bioanalysis Services Product Solution and Service
3.7 Date of Enter into Drug Bioanalysis Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Bioanalysis Services Breakdown Data by Type
4.1 Global Drug Bioanalysis Services Historic Market Size by Type (2019-2024)
4.2 Global Drug Bioanalysis Services Forecasted Market Size by Type (2025-2030)
5 Drug Bioanalysis Services Breakdown Data by Application
5.1 Global Drug Bioanalysis Services Historic Market Size by Application (2019-2024)
5.2 Global Drug Bioanalysis Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Bioanalysis Services Market Size (2019-2030)
6.2 North America Drug Bioanalysis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Bioanalysis Services Market Size by Country (2019-2024)
6.4 North America Drug Bioanalysis Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Bioanalysis Services Market Size (2019-2030)
7.2 Europe Drug Bioanalysis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Bioanalysis Services Market Size by Country (2019-2024)
7.4 Europe Drug Bioanalysis Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Bioanalysis Services Market Size (2019-2030)
8.2 Asia-Pacific Drug Bioanalysis Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Bioanalysis Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Bioanalysis Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Bioanalysis Services Market Size (2019-2030)
9.2 Latin America Drug Bioanalysis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Bioanalysis Services Market Size by Country (2019-2024)
9.4 Latin America Drug Bioanalysis Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Bioanalysis Services Market Size (2019-2030)
10.2 Middle East & Africa Drug Bioanalysis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Bioanalysis Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Bioanalysis Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intertek
11.1.1 Intertek Company Detail
11.1.2 Intertek Business Overview
11.1.3 Intertek Drug Bioanalysis Services Introduction
11.1.4 Intertek Revenue in Drug Bioanalysis Services Business (2019-2024)
11.1.5 Intertek Recent Development
11.2 SGS
11.2.1 SGS Company Detail
11.2.2 SGS Business Overview
11.2.3 SGS Drug Bioanalysis Services Introduction
11.2.4 SGS Revenue in Drug Bioanalysis Services Business (2019-2024)
11.2.5 SGS Recent Development
11.3 Medicilon
11.3.1 Medicilon Company Detail
11.3.2 Medicilon Business Overview
11.3.3 Medicilon Drug Bioanalysis Services Introduction
11.3.4 Medicilon Revenue in Drug Bioanalysis Services Business (2019-2024)
11.3.5 Medicilon Recent Development
11.4 PPD, Inc.
11.4.1 PPD, Inc. Company Detail
11.4.2 PPD, Inc. Business Overview
11.4.3 PPD, Inc. Drug Bioanalysis Services Introduction
11.4.4 PPD, Inc. Revenue in Drug Bioanalysis Services Business (2019-2024)
11.4.5 PPD, Inc. Recent Development
11.5 ICON Plc
11.5.1 ICON Plc Company Detail
11.5.2 ICON Plc Business Overview
11.5.3 ICON Plc Drug Bioanalysis Services Introduction
11.5.4 ICON Plc Revenue in Drug Bioanalysis Services Business (2019-2024)
11.5.5 ICON Plc Recent Development
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Detail
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Drug Bioanalysis Services Introduction
11.6.4 Eurofins Scientific Revenue in Drug Bioanalysis Services Business (2019-2024)
11.6.5 Eurofins Scientific Recent Development
11.7 Charles River Laboratories International
11.7.1 Charles River Laboratories International Company Detail
11.7.2 Charles River Laboratories International Business Overview
11.7.3 Charles River Laboratories International Drug Bioanalysis Services Introduction
11.7.4 Charles River Laboratories International Revenue in Drug Bioanalysis Services Business (2019-2024)
11.7.5 Charles River Laboratories International Recent Development
11.8 Impact Analytical
11.8.1 Impact Analytical Company Detail
11.8.2 Impact Analytical Business Overview
11.8.3 Impact Analytical Drug Bioanalysis Services Introduction
11.8.4 Impact Analytical Revenue in Drug Bioanalysis Services Business (2019-2024)
11.8.5 Impact Analytical Recent Development
11.9 QPS
11.9.1 QPS Company Detail
11.9.2 QPS Business Overview
11.9.3 QPS Drug Bioanalysis Services Introduction
11.9.4 QPS Revenue in Drug Bioanalysis Services Business (2019-2024)
11.9.5 QPS Recent Development
11.10 Frontage Laboratories
11.10.1 Frontage Laboratories Company Detail
11.10.2 Frontage Laboratories Business Overview
11.10.3 Frontage Laboratories Drug Bioanalysis Services Introduction
11.10.4 Frontage Laboratories Revenue in Drug Bioanalysis Services Business (2019-2024)
11.10.5 Frontage Laboratories Recent Development
11.11 ACM Global Laboratories
11.11.1 ACM Global Laboratories Company Detail
11.11.2 ACM Global Laboratories Business Overview
11.11.3 ACM Global Laboratories Drug Bioanalysis Services Introduction
11.11.4 ACM Global Laboratories Revenue in Drug Bioanalysis Services Business (2019-2024)
11.11.5 ACM Global Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Drug Bioanalysis Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Macro Molecular Drug Bioanalysis
Table 3. Key Players of Small Molecule Drug Bioanalysis
Table 4. Global Drug Bioanalysis Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Drug Bioanalysis Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Drug Bioanalysis Services Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Drug Bioanalysis Services Market Share by Region (2019-2024)
Table 8. Global Drug Bioanalysis Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Drug Bioanalysis Services Market Share by Region (2025-2030)
Table 10. Drug Bioanalysis Services Market Trends
Table 11. Drug Bioanalysis Services Market Drivers
Table 12. Drug Bioanalysis Services Market Challenges
Table 13. Drug Bioanalysis Services Market Restraints
Table 14. Global Drug Bioanalysis Services Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Drug Bioanalysis Services Market Share by Players (2019-2024)
Table 16. Global Top Drug Bioanalysis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Bioanalysis Services as of 2023)
Table 17. Ranking of Global Top Drug Bioanalysis Services Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Drug Bioanalysis Services Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Bioanalysis Services Product Solution and Service
Table 21. Date of Enter into Drug Bioanalysis Services Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Bioanalysis Services Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Drug Bioanalysis Services Revenue Market Share by Type (2019-2024)
Table 25. Global Drug Bioanalysis Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Drug Bioanalysis Services Revenue Market Share by Type (2025-2030)
Table 27. Global Drug Bioanalysis Services Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Drug Bioanalysis Services Revenue Market Share by Application (2019-2024)
Table 29. Global Drug Bioanalysis Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Drug Bioanalysis Services Revenue Market Share by Application (2025-2030)
Table 31. North America Drug Bioanalysis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Drug Bioanalysis Services Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Drug Bioanalysis Services Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Drug Bioanalysis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Drug Bioanalysis Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Drug Bioanalysis Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Drug Bioanalysis Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Drug Bioanalysis Services Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Drug Bioanalysis Services Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Bioanalysis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Drug Bioanalysis Services Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Drug Bioanalysis Services Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Drug Bioanalysis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Drug Bioanalysis Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Drug Bioanalysis Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. Intertek Company Detail
Table 47. Intertek Business Overview
Table 48. Intertek Drug Bioanalysis Services Product
Table 49. Intertek Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 50. Intertek Recent Development
Table 51. SGS Company Detail
Table 52. SGS Business Overview
Table 53. SGS Drug Bioanalysis Services Product
Table 54. SGS Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 55. SGS Recent Development
Table 56. Medicilon Company Detail
Table 57. Medicilon Business Overview
Table 58. Medicilon Drug Bioanalysis Services Product
Table 59. Medicilon Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 60. Medicilon Recent Development
Table 61. PPD, Inc. Company Detail
Table 62. PPD, Inc. Business Overview
Table 63. PPD, Inc. Drug Bioanalysis Services Product
Table 64. PPD, Inc. Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 65. PPD, Inc. Recent Development
Table 66. ICON Plc Company Detail
Table 67. ICON Plc Business Overview
Table 68. ICON Plc Drug Bioanalysis Services Product
Table 69. ICON Plc Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 70. ICON Plc Recent Development
Table 71. Eurofins Scientific Company Detail
Table 72. Eurofins Scientific Business Overview
Table 73. Eurofins Scientific Drug Bioanalysis Services Product
Table 74. Eurofins Scientific Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 75. Eurofins Scientific Recent Development
Table 76. Charles River Laboratories International Company Detail
Table 77. Charles River Laboratories International Business Overview
Table 78. Charles River Laboratories International Drug Bioanalysis Services Product
Table 79. Charles River Laboratories International Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 80. Charles River Laboratories International Recent Development
Table 81. Impact Analytical Company Detail
Table 82. Impact Analytical Business Overview
Table 83. Impact Analytical Drug Bioanalysis Services Product
Table 84. Impact Analytical Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 85. Impact Analytical Recent Development
Table 86. QPS Company Detail
Table 87. QPS Business Overview
Table 88. QPS Drug Bioanalysis Services Product
Table 89. QPS Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 90. QPS Recent Development
Table 91. Frontage Laboratories Company Detail
Table 92. Frontage Laboratories Business Overview
Table 93. Frontage Laboratories Drug Bioanalysis Services Product
Table 94. Frontage Laboratories Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 95. Frontage Laboratories Recent Development
Table 96. ACM Global Laboratories Company Detail
Table 97. ACM Global Laboratories Business Overview
Table 98. ACM Global Laboratories Drug Bioanalysis Services Product
Table 99. ACM Global Laboratories Revenue in Drug Bioanalysis Services Business (2019-2024) & (US$ Million)
Table 100. ACM Global Laboratories Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Bioanalysis Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drug Bioanalysis Services Market Share by Type: 2023 VS 2030
Figure 3. Macro Molecular Drug Bioanalysis Features
Figure 4. Small Molecule Drug Bioanalysis Features
Figure 5. Global Drug Bioanalysis Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Drug Bioanalysis Services Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Development Corporation Case Studies
Figure 8. Hospital Case Studies
Figure 9. Academic Research Institute Case Studies
Figure 10. Others Case Studies
Figure 11. Drug Bioanalysis Services Report Years Considered
Figure 12. Global Drug Bioanalysis Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Drug Bioanalysis Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drug Bioanalysis Services Market Share by Region: 2023 VS 2030
Figure 15. Global Drug Bioanalysis Services Market Share by Players in 2023
Figure 16. Global Top Drug Bioanalysis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Bioanalysis Services as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Drug Bioanalysis Services Revenue in 2023
Figure 18. North America Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Drug Bioanalysis Services Market Share by Country (2019-2030)
Figure 20. United States Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Drug Bioanalysis Services Market Share by Country (2019-2030)
Figure 24. Germany Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Drug Bioanalysis Services Market Share by Region (2019-2030)
Figure 32. China Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Drug Bioanalysis Services Market Share by Country (2019-2030)
Figure 40. Mexico Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Drug Bioanalysis Services Market Share by Country (2019-2030)
Figure 44. Turkey Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Drug Bioanalysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Intertek Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 47. SGS Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 48. Medicilon Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 49. PPD, Inc. Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 50. ICON Plc Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 51. Eurofins Scientific Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 52. Charles River Laboratories International Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 53. Impact Analytical Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 54. QPS Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 55. Frontage Laboratories Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 56. ACM Global Laboratories Revenue Growth Rate in Drug Bioanalysis Services Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
